Siemens Healthineers’ (SHL) Neutral Rating Reiterated at UBS Group

UBS Group restated their neutral rating on shares of Siemens Healthineers (ETR:SHL) in a research note released on Monday, Borsen Zeitung reports.

Several other analysts have also recently weighed in on the company. JPMorgan Chase & Co. set a €37.10 ($43.14) price target on Siemens Healthineers and gave the stock a sell rating in a report on Tuesday, February 4th. Credit Suisse Group set a €36.00 ($41.86) price target on Siemens Healthineers and gave the stock a buy rating in a report on Wednesday, March 18th. Royal Bank of Canada set a €41.00 ($47.67) price objective on Siemens Healthineers and gave the company a neutral rating in a report on Monday, February 3rd. Deutsche Bank set a €40.00 ($46.51) price objective on Siemens Healthineers and gave the company a neutral rating in a report on Tuesday, February 4th. Finally, Berenberg Bank set a €50.00 ($58.14) price objective on Siemens Healthineers and gave the company a buy rating in a report on Friday, February 7th. Two research analysts have rated the stock with a sell rating, nine have assigned a hold rating and six have assigned a buy rating to the company’s stock. Siemens Healthineers presently has an average rating of Hold and an average target price of €41.38 ($48.12).

ETR:SHL opened at €36.09 ($41.97) on Monday. The stock has a market cap of $36.07 billion and a P/E ratio of 23.62. The stock has a 50 day simple moving average of €37.30 and a 200 day simple moving average of €39.66. The company has a current ratio of 1.32, a quick ratio of 0.87 and a debt-to-equity ratio of 5.01. Siemens Healthineers has a 1-year low of €31.42 ($36.53) and a 1-year high of €45.20 ($52.56).

Siemens Healthineers Company Profile

Siemens Healthineers AG develops, manufactures, and distributes imaging, advanced therapies, and diagnostic products and services to healthcare providers worldwide. It operates in three operating segments: Imaging, Advanced Therapies, and Diagnostics. The Imaging segment provides diagnostic imaging and ultrasound systems and solutions.

Further Reading: What are the advantages of the Stochastic Momentum Index?

Analyst Recommendations for Siemens Healthineers (ETR:SHL)

Receive News & Ratings for Siemens Healthineers Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Siemens Healthineers and related companies with MarketBeat.com's FREE daily email newsletter.